Back for good

June 2004

RPL is delighted to welcome Clinical Trials Assistant, Bibbi Jilka back to the company after a short spell at Parexel. Bibbi first joined RPL in 2002, having previously worked with Managing Director, Dr Jörg Täubel and Medical Director, Ulrike Lorch at another company. She returned to RPL after just seven months at Parexel.‘I missed RPL's warm friendly environment. It is really exciting to work within a multidisciplinary team with direct access to the Medical Director and the Head Nurse. I am learning all the time and making the most of my training.’In the turn the RPL Directors are pleased to have Bibbi back. Jörg Täubel said, ‘it's very rewarding to hear that RPL offers a stimulating work environment. We want to develop staff to their maximum potential with good training and as much encouragement as possible. We've known Bibbi for a long time and it's great to have her back.’

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more